ZA201202307B - Salts, solvents, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same - Google Patents
Salts, solvents, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the sameInfo
- Publication number
- ZA201202307B ZA201202307B ZA2012/02307A ZA201202307A ZA201202307B ZA 201202307 B ZA201202307 B ZA 201202307B ZA 2012/02307 A ZA2012/02307 A ZA 2012/02307A ZA 201202307 A ZA201202307 A ZA 201202307A ZA 201202307 B ZA201202307 B ZA 201202307B
- Authority
- ZA
- South Africa
- Prior art keywords
- solvents
- salts
- methods
- pharmaceutical compositions
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D269/00—Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24736209P | 2009-09-30 | 2009-09-30 | |
PCT/US2010/050661 WO2011041369A1 (en) | 2009-09-30 | 2010-09-29 | Salts, solvates, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201202307B true ZA201202307B (en) | 2012-12-27 |
Family
ID=43826618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2012/02307A ZA201202307B (en) | 2009-09-30 | 2012-03-29 | Salts, solvents, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same |
Country Status (14)
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921521B2 (en) | 2003-06-18 | 2014-12-30 | Ocera Therapeutics, Inc. | Macrocyclic modulators of the Ghrelin receptor |
US7476653B2 (en) * | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
WO2004111077A1 (en) * | 2003-06-18 | 2004-12-23 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor |
US20090198050A1 (en) * | 2003-06-18 | 2009-08-06 | Tranzyme Pharma Inc. | Macrocyclic Modulators of the Ghrelin Receptor |
EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
SI2603600T1 (sl) | 2010-08-13 | 2019-04-30 | Aileron Therapeutics, Inc. | Peptidomimetični makrocikli |
UY34094A (es) | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
AU2012326026B2 (en) | 2011-10-18 | 2017-04-13 | Aileron Therapeutics, Inc. | Peptidomimetic macrocyles |
WO2013123267A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
CN112500466B (zh) | 2012-02-15 | 2022-05-03 | 艾瑞朗医疗公司 | 拟肽大环化合物 |
AU2013337388B2 (en) | 2012-11-01 | 2018-08-02 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
BR112017005598A2 (pt) | 2014-09-24 | 2017-12-12 | Aileron Therapeutics Inc | macrociclos peptidomiméticos e usos dos mesmos |
SG11201703884PA (en) | 2014-11-12 | 2017-06-29 | Lyric Pharmaceuticals Inc | Treatment of enteral feeding intolerance |
KR20170129879A (ko) | 2015-03-20 | 2017-11-27 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방 거대고리 및 이의 용도 |
EP4252629A3 (en) * | 2016-12-07 | 2023-12-27 | Biora Therapeutics, Inc. | Gastrointestinal tract detection methods, devices and systems |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7476653B2 (en) * | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
KR20070009574A (ko) * | 2004-02-17 | 2007-01-18 | 토마스 이. 존슨 | 매크로사이클릭 화합물의 형성을 위한 방법, 조성물 및장치 |
CN102816194A (zh) * | 2004-02-27 | 2012-12-12 | 瑞伯-X医药品有限公司 | 大环化合物以及其制作和使用方法 |
US8088733B2 (en) * | 2006-07-06 | 2012-01-03 | Tranzyme Pharma Inc. | Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
-
2010
- 2010-09-29 WO PCT/US2010/050661 patent/WO2011041369A1/en active Application Filing
- 2010-09-29 BR BR112012007183A patent/BR112012007183A2/pt not_active IP Right Cessation
- 2010-09-29 AU AU2010300689A patent/AU2010300689A1/en not_active Abandoned
- 2010-09-29 EP EP10821147A patent/EP2482813A4/en not_active Withdrawn
- 2010-09-29 EA EA201270497A patent/EA201270497A1/ru unknown
- 2010-09-29 CN CN2010800547916A patent/CN102781441A/zh active Pending
- 2010-09-29 JP JP2012532258A patent/JP2013506676A/ja not_active Withdrawn
- 2010-09-29 MX MX2012003912A patent/MX2012003912A/es not_active Application Discontinuation
- 2010-09-29 KR KR1020127010634A patent/KR20120081166A/ko not_active Application Discontinuation
- 2010-09-29 IN IN3297DEN2012 patent/IN2012DN03297A/en unknown
- 2010-09-29 CA CA2775925A patent/CA2775925A1/en not_active Abandoned
- 2010-09-29 US US12/937,040 patent/US20110245159A1/en not_active Abandoned
-
2012
- 2012-03-29 ZA ZA2012/02307A patent/ZA201202307B/en unknown
- 2012-03-29 IL IL218938A patent/IL218938A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IN2012DN03297A (US07521420-20090421-C00691.png) | 2015-10-23 |
KR20120081166A (ko) | 2012-07-18 |
EP2482813A4 (en) | 2013-02-27 |
US20110245159A1 (en) | 2011-10-06 |
MX2012003912A (es) | 2012-08-17 |
AU2010300689A1 (en) | 2012-04-19 |
CN102781441A (zh) | 2012-11-14 |
CA2775925A1 (en) | 2011-04-07 |
BR112012007183A2 (pt) | 2017-06-20 |
JP2013506676A (ja) | 2013-02-28 |
IL218938A0 (en) | 2012-07-31 |
EP2482813A1 (en) | 2012-08-08 |
EA201270497A1 (ru) | 2012-10-30 |
WO2011041369A1 (en) | 2011-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201202307B (en) | Salts, solvents, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same | |
HK1164050A1 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
ZA201105323B (en) | Agonists and antagonists of the sip5 receptor,and methods of uses thereof | |
IL214175A (en) | Derivatives of aminotetralin, their pharmaceutical compositions and their use | |
IL214425A (en) | Converted metastatic heterocyclic compounds, their pharmaceutical preparations and their uses | |
SI2547679T1 (sl) | Derivati 2,3 dihidro-1H-inden-1-il-2,7-diazaspiro(3.6)nonana in njihova uporaba kot antagonisti ali inverzni agonisti grelinskega receptorja | |
HK1161878A1 (en) | Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof | |
IL216113A (en) | Processed derivatives of indazole and azaza-indazole, pharmaceutical preparations containing them and their uses | |
EP2562172A4 (en) | SPHAELACTON DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION AND THEIR USE | |
HK1198287A1 (en) | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives 2--1- | |
IL216388A0 (en) | New compounds, pharmaceutical composition and methods relating thereto | |
HK1209649A1 (en) | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives 2--1- | |
EP2615092A4 (en) | HETEROCYCLIC AMINO BAMINE DERIVATIVES, METHOD OF MANUFACTURING THEREOF AND USE THEREOF | |
IL212942A (en) | History of Rifamycin, Methods of Preparation, Pharmaceutical Preparations Containing Them and Their Uses | |
EP2386553A4 (en) | BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
IL213590A0 (en) | Oxadiazole fused heterocyclic derivatives, their preparation and pharmaceutical compositions containing them | |
EP2536285A4 (en) | SUBSTITUTED CONDENSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOUNDS AND USER METHOD THEREFOR | |
EP2504331A4 (en) | COMPOUND, SOME NEW FORMS THEREOF, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF PREPARATION AND USE | |
SI2508206T1 (sl) | Sredstvo za filmsko oblogo za trden pripravek in trden pripravek, ki ga uporablja | |
IL213588A0 (en) | Naphthyridine derivatives, their preparation and pharmaceutical compositions containing them | |
EP2562156A4 (en) | DERIVATIVES OF COLCHICINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PROCESS FOR THE PREPARATION OF SAID DERIVATIVES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAID DERIVATIVES | |
EP2452681A4 (en) | SALTS OF 13A- (S-) DESOXYTYLPHORININE, METHOD FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF | |
IL225209A0 (en) | History of dihydrobenzoxathiazpine, their preparation, pharmaceutical preparations and use as ampa receptor modulators | |
EP2626352A4 (en) | HETEROCYCLIC MIMETICS, LOW MOLECULAR WEIGHT, SAPP, PHARMACEUTICAL COMPOSITION AND METHODS OF MAKING AND USING SAME | |
ZA201200165B (en) | 2-amino-2phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |